International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines (Q30431960)

21 June 2017

title

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines (English)

1 reference

21 June 2017

main subject

Guillain–Barré syndrome

0 references

1 reference

Nicoline van der Maas

32

Nicoline van der Maas

0 references

Harald Heijbel

16

Harald Heijbel

0 references

Barbara G. Silverman

Barbara Silverman

29

0 references

Daniel A Salmon

Daniel Salmon

26

0 references

Anders Hviid

Anders Hviid

19

0 references

Jan Bonhoeffer

9

Jan Bonhoeffer

1 reference

21 June 2017

5

Nick Andrews

1 reference

21 June 2017

10

Jim Buttery

1 reference

21 June 2017

4

Claudia Vellozzi

1 reference

21 June 2017

7

Patrick Zuber

1 reference

ORCID Public Data File 2021

21 June 2017

1 reference

Miriam Sturkenboom

6

Miriam Sturkenboom

1 reference

21 June 2017

23

Kristine Macartney

1 reference

21 June 2017

11

Nigel Crawford

1 reference

21 June 2017

Caitlin N Dodd

1

1 reference

21 June 2017

Silvana A Romio

2

1 reference

21 June 2017

Steven Black

3

1 reference

21 June 2017

Wei Hua

8

1 reference

21 June 2017

Genevieve Deceuninck

12

1 reference

21 June 2017

Corinne de Vries

13

1 reference

21 June 2017

Philippe De Wals

14

1 reference

21 June 2017

M Victoria Gutierrez-Gimeno

15

1 reference

21 June 2017

Harald Heijbel

16

1 reference

21 June 2017

Hayley Hughes

17

1 reference

21 June 2017

Kwan Hur

18

1 reference

21 June 2017

Jeffrey Kelman

20

1 reference

21 June 2017

Tehri Kilpi

21

1 reference

21 June 2017

S K Chuang

22

1 reference

21 June 2017

Melisa Rett

24

1 reference

21 June 2017

Vesta Richardson Lopez-Callada

25

1 reference

21 June 2017

Francisco Gimenez-Sanchez

27

1 reference

21 June 2017

Nuria Sanz

28

1 reference

21 June 2017

Jann Storsaeter

30

1 reference

21 June 2017

Umapathi Thirugnanam

31

1 reference

21 June 2017

Nicoline van der Maas

32

1 reference

21 June 2017

Katherine Yih

33

1 reference

21 June 2017

Tao Zhang

34

1 reference

21 June 2017

Hector Izurieta

35

1 reference

21 June 2017

Global H1N1 GBS Consortium

36

1 reference

21 June 2017

language of work or name

English

0 references

publication date

14 June 2013

1 reference

21 June 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

21 June 2017

volume

31

1 reference

21 June 2017

issue

40

1 reference

21 June 2017

page(s)

4448-4458

1 reference

The introduction of new vaccines into developing countries. IV: Global Access Strategies

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Tutorial in biostatistics: the self-controlled case series method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Relative incidence estimation from case series for vaccine safety evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Confounding in studies of adverse reactions to vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

When should case-only designs be used for safety monitoring of medical products?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Case series analysis for censored, perturbed, or curtailed post-event exposures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Meta-analysis in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Guillain-Barré syndrome following influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2009-2010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Guillain-Barr� syndrome: Its epidemiology and associations with influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Clinical and epidemiologic features of Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Guillain-Barré syndrome incidence in a large United States cohort (2000-2009).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Biology of immune responses to vaccines in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Lack of association between acellular pertussis vaccine and seizures in early childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

Does oral polio vaccine cause intussusception in infants? Evidence from a sequence of three self-controlled cases series studies in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.032

10.1016/J.VACCINE.2013.06.032

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference